Why the study?
Does local chemotherapy improve effusion-free survival in patients with malignant pericardial effusion?
Population
139 patients with malignant pericardial effusion (MPE) due to various neoplasms (88 with lung cancer)
Design
Editorial
Follow-up
12 months
Authors
Loading...
Local chemotherapy with platinum for malignant pericardial effusion is proposed as a safer and more rational alternative to sclerosing therapy, demonstrating favorable effusion-free survival.
Does local chemotherapy improve effusion-free survival in patients with malignant pericardial effusion?
Local chemotherapy with platinum for malignant pericardial effusion is proposed as a safer and more rational alternative to sclerosing therapy, demonstrating favorable effusion-free survival.
Lestuzzi et al. (2009) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: